Table III. —Treatment effects and period effects between MFR and placebo MFR.
| Outcome (units) | Treatment effect | Period effect | ||
|---|---|---|---|---|
| MD | 95% CI | MD | 95% CI | |
| Pain (NRS) | 1.27 | 0.76 to 1.78 | 0.13 | -0.57 to 0.83 |
| Shoulder ROM - flexion | -8.30 | -12.98 to -3.62 | -3.37 | -8.86 to 2.13 |
| Shoulder ROM - extension | -3.47 | -5.90 to -1.03 | 1.13 | -1.60 to 3.87 |
| Shoulder ROM - abduction | -9.70 | -12.31 to -7.09 | 0.77 | -3.74 to 5.27 |
| Shoulder ROM - adduction | -2.07 | -3.81 to -0.32 | 0.80 | -1.09 to 2.69 |
| Shoulder ROM - internal rotation | -0.30 | -2.54 to 1.94 | 1.37 | -0.82 to 3.55 |
| Shoulder ROM - external rotation | -5.23 | -6.83 to -3.64 | 0.03 | -2.51 to 2.58 |
| Chest mobility | -0.22 | -0.43 to -0.02 | -0.43 | -0.27 to 0.18 |
| Shoulder function (DASH) | 3.19 | 1.47 to 4.90 | -1.46 | -3.49 to 0.57 |
| Quality of life (FACT-B) | 1.73 | -0.25 to 3.72 | 3.47 | -1.84 to 5.09 |
MD: mean difference; 95% CI: 95% confidence interval; MFR: myofascial release; ROM: range of motion; DASH: Disabilities of the Arm: Shoulder and Head; FACT-B: Functional Assessment of Cancer Therapy for Breast Cancer Patients.